DK2976355T3 - Vaccines against chlamydia sp - Google Patents

Vaccines against chlamydia sp Download PDF

Info

Publication number
DK2976355T3
DK2976355T3 DK14721199.9T DK14721199T DK2976355T3 DK 2976355 T3 DK2976355 T3 DK 2976355T3 DK 14721199 T DK14721199 T DK 14721199T DK 2976355 T3 DK2976355 T3 DK 2976355T3
Authority
DK
Denmark
Prior art keywords
vaccines against
against chlamydia
chlamydia
vaccines
Prior art date
Application number
DK14721199.9T
Other languages
Danish (da)
English (en)
Inventor
Anja Olsen
Peter Lawætz Andersen
Frank Follmann
Ida Rosenkrands
Original Assignee
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Seruminstitut filed Critical Statens Seruminstitut
Application granted granted Critical
Publication of DK2976355T3 publication Critical patent/DK2976355T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK14721199.9T 2013-03-18 2014-03-17 Vaccines against chlamydia sp DK2976355T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201300155 2013-03-18
DKPA201300684 2013-12-11
PCT/DK2014/000015 WO2014146663A1 (en) 2013-03-18 2014-03-17 Vaccines against chlamydia sp.

Publications (1)

Publication Number Publication Date
DK2976355T3 true DK2976355T3 (en) 2020-03-30

Family

ID=50639248

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14721199.9T DK2976355T3 (en) 2013-03-18 2014-03-17 Vaccines against chlamydia sp

Country Status (20)

Country Link
US (4) US20140275478A1 (enExample)
EP (1) EP2976355B1 (enExample)
JP (3) JP2016514713A (enExample)
CN (2) CN113185587A (enExample)
AU (1) AU2014234765B2 (enExample)
BR (1) BR112015023886B1 (enExample)
CA (1) CA2907199C (enExample)
CY (1) CY1122905T1 (enExample)
DK (1) DK2976355T3 (enExample)
ES (1) ES2781579T3 (enExample)
HR (1) HRP20200511T1 (enExample)
HU (1) HUE048573T2 (enExample)
LT (1) LT2976355T (enExample)
PL (1) PL2976355T3 (enExample)
PT (1) PT2976355T (enExample)
RS (1) RS60135B1 (enExample)
RU (1) RU2723046C2 (enExample)
SI (1) SI2976355T1 (enExample)
SM (1) SMT202000160T1 (enExample)
WO (1) WO2014146663A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016130667A1 (en) 2015-02-10 2016-08-18 Ohio State Innovation Foundation Chlamydia-activated b cell platforms and methods thereof
CN104800841B (zh) * 2015-03-02 2019-04-02 中国农业科学院兰州兽医研究所 牦牛流产衣原体灭活疫苗及其制备方法
ES2734261T3 (es) * 2015-03-24 2019-12-05 Univ Gent Procedimiento y péptidos para la detección de Chlamidia suis
WO2017075653A1 (en) * 2015-11-04 2017-05-11 University Of The Sunshine Coast Chlamydia antigens and uses thereof
JP7086000B2 (ja) 2015-11-10 2022-06-17 オハイオ・ステート・イノヴェーション・ファウンデーション 体液性親和性の加速に関する方法及び組成物
NL2019320B1 (en) * 2017-03-02 2018-09-21 Biosparq B V Diagnostic method and system for diagnosis
EP3600401A1 (en) * 2017-03-23 2020-02-05 Ohio State Innovation Foundation Recombinant chlamydia-activated b cell platforms and methods of use thereof
RU2721123C1 (ru) * 2019-09-26 2020-05-18 федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации Штамм рекомбинантной псевдоаденовирусной частицы, экспрессирующий химерный ген MBL-CT666 Chlamydia trachomatis, способ его получения, иммуногенная композиция для защиты от урогенитального хламидиоза человека
KR20230124672A (ko) * 2020-12-23 2023-08-25 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 항원 제시 세포에 대한 momp vs4 항원의 표적화에 기반한클라미디아 백신
CN116854812B (zh) * 2022-03-23 2024-09-24 东莞市朋志生物科技有限公司 抗沙眼衣原体的抗体、检测沙眼衣原体的试剂和试剂盒
CN115975049A (zh) * 2022-11-12 2023-04-18 北京成大天和生物科技有限公司 一种沙眼衣原体重组蛋白及其制备方法和应用
AU2024228998A1 (en) 2023-03-02 2025-10-16 Sanofi Pasteur Compositions for use in treatment of chlamydia
WO2025104023A1 (en) 2023-11-13 2025-05-22 Ziphius Nv MODIFIED ALPHAVIRAL nsP3

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599230A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4599231A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4608251A (en) 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
US4601903A (en) 1985-05-01 1986-07-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
US5869608A (en) * 1989-03-17 1999-02-09 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis
US5837268A (en) * 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
GB9215780D0 (en) * 1992-07-24 1992-09-09 Univ London Pharmacy Peptide compounds
WO1994003615A1 (en) * 1992-07-31 1994-02-17 Medeva Holdings B.V. Expression of recombinant fusion proteins in attenuated bacteria
JPH08504188A (ja) 1992-09-18 1996-05-07 アメリカ合衆国 トラコーマクラミジアの合成ペプチドワクチン
GB9516293D0 (en) * 1995-08-09 1995-10-11 Immunova Ltee Novel peptides and their use as vaccines
JP2002512622A (ja) * 1997-05-06 2002-04-23 バンダービルト ユニバーシティー クラミジアにより引き起こされる感染の診断および管理のための抗クラミジア剤の組成物
US7651857B2 (en) * 2000-12-22 2010-01-26 The Mathilda And Terence Kennedy Institute Of Rheumatology Trust Methods for enhancing antigen presentation
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
US20100255002A1 (en) * 2003-06-26 2010-10-07 Chiron Corporation Immunogenic compositions for chlamydia trachomatis
PT1812058E (pt) * 2004-10-25 2012-09-17 Statens Seruminstitut Antigénios de chlamydia trachomatis para vacina e utilização em diagnóstico
CA2609038A1 (en) * 2005-05-18 2006-11-23 Trinity Biosystems, Inc. Methods and compositions for immunizing against chlamydia infection
TW201012929A (en) * 2008-09-29 2010-04-01 Univ Nat Pingtung Sci & Tech A hybridoma cell line producing monoclonal antibodies against chalmydophila aborts
CA2787697C (en) * 2009-01-29 2018-03-20 British Columbia Cancer Agency Branch Compositions comprising chlamydia antigens
EP2576602B1 (en) * 2010-05-28 2020-02-12 Spixia Biotechnology AB Chimeric momp antigen, method and use
WO2012172042A1 (en) * 2011-06-17 2012-12-20 Universiteit Gent Vaccines for chlamydia

Also Published As

Publication number Publication date
AU2014234765B2 (en) 2018-01-25
US20190099478A1 (en) 2019-04-04
LT2976355T (lt) 2020-04-10
JP7510142B2 (ja) 2024-07-03
US20250255951A1 (en) 2025-08-14
JP2019163253A (ja) 2019-09-26
WO2014146663A1 (en) 2014-09-25
US20140275478A1 (en) 2014-09-18
CN113185587A (zh) 2021-07-30
US20210205433A1 (en) 2021-07-08
JP2016514713A (ja) 2016-05-23
ES2781579T3 (es) 2020-09-03
AU2014234765A1 (en) 2015-10-08
JP7506930B2 (ja) 2024-06-27
CN105377879A (zh) 2016-03-02
JP2021193123A (ja) 2021-12-23
HUE048573T2 (hu) 2020-08-28
PT2976355T (pt) 2020-04-02
SI2976355T1 (sl) 2020-07-31
EP2976355B1 (en) 2020-01-01
BR112015023886B1 (pt) 2023-05-16
RU2723046C2 (ru) 2020-06-08
CY1122905T1 (el) 2021-10-29
CN105377879B (zh) 2021-05-04
HRP20200511T1 (hr) 2020-06-26
RU2015141214A (ru) 2017-04-26
CA2907199C (en) 2023-10-17
US10925954B2 (en) 2021-02-23
BR112015023886A2 (pt) 2017-10-24
RS60135B1 (sr) 2020-05-29
SMT202000160T1 (it) 2020-05-08
CA2907199A1 (en) 2014-09-25
EP2976355A1 (en) 2016-01-27
PL2976355T3 (pl) 2020-07-13

Similar Documents

Publication Publication Date Title
IL276210B1 (en) Mers-cov vaccine
DK3736291T3 (en) Anti-FCRH5-antistoffer
DK3077519T3 (en) Cmv-vacciner
DK2976355T3 (en) Vaccines against chlamydia sp
EP2950428A4 (en) ACTUATOR
AU356420S (en) Blower
GB2510208B (en) Actuator
DK3470074T3 (en) Probiotika
DK3056208T3 (en) Immunpotentiator
PL2958935T3 (pl) Szczepionka
GB201301329D0 (en) Fluidfoil
GB201312869D0 (en) Actuator
GB201317144D0 (en) Elongate Member
GB201313535D0 (en) Hairdryers
PL2784312T3 (pl) Siłownik
EP3014557A4 (en) TELEPHONE ON FILE
GB201320646D0 (en) Vaccine
GB201315556D0 (en) Vaccine
GB201320421D0 (en) Conjugated vaccine
GB201307873D0 (en) Retaining device
GB201318389D0 (en) Actuator
GB201318451D0 (en) W/C Sani-vent
GB201310308D0 (en) Damage limitation
GB201304119D0 (en) Hairdryers
AU353327S (en) Kettlebell